FTI 277 TFA

FTI 277 TFA
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T41212-25mg 25 mg -

7 - 10 business days*

1,491.00€
 
Description: FTI 277 TFA is a prodrug form of FTI 276 that inhibits farnesyltransferase (FTase)... more
Product information "FTI 277 TFA"
Description: FTI 277 TFA is a prodrug form of FTI 276 that inhibits farnesyltransferase (FTase) (IC50 = 0.5 nM). Inhibits H-Ras and K-Ras processing in whole cells (IC50 values are 0.1 and 10µM respectively) and disrupts constitutive H-Ras-specific activation of MAPK. Causes significant antiproliferative effects in human malignant glioma cells and many other tumor cell lines. Target: Others. Smiles: OC(=O)C(F)(F)F.COC(=O)[C@H](CCSC)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1ccccc1. References: Lerner et al (1995) Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling inducing cytoplasic accumulation of inactive Ras-Raf complexes. J.Biol.Chem. 270 26802 PMID: 7592920
Supplier: TargetMol
Supplier-Nr: T41212

Properties

Application: Farnesyltransferase inhibitor
MW: 561.64 D
Formula: C24H30F3N3O5S2

Database Information

CAS : 1217447-06-7| Matching products
KEGG ID : K05954 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "FTI 277 TFA"
Write a review
or to review a product.
Viewed